Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV000755675 | SCV000221465 | uncertain significance | Arrhythmogenic right ventricular dysplasia 10 | 2024-06-08 | criteria provided, single submitter | research | Downgraded variant due to updated local frequency |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000171268 | SCV000697882 | likely benign | not provided | 2016-02-01 | criteria provided, single submitter | clinical testing | Variant summary: DSG2 c.1376A>G variant affects a conserved nucleotide, resulting in amino acid change from Tyr to Cys. 4/4 in-silico tools predict a damaging outcome for this variant, however, functional studies have not been carried out to confirm these predictions. This variant is found in 139/111860 control chromosomes (5 homozygotes) at a frequency of 0.0012426. The variant is predominantly found in South Asians (132/15646; 0.0084367). These frequencies are 124-843 times the maximal expected frequency of a pathogenic DSG2 allele (0.00001), highly suggesting this variant is benign. Additionally, the variant has been reported in 1 HCM patient to co-occur with a pathogenic variant, TNNT2 R92W. Although one research center reports this variant as likely pathogenic, they provide no evidence to independently evaluate. Taken together, this is probably a normal variant given the high frequency in controls and at least one reported co-occurrence with a pathogenic TNNT2 allele, thus this DSG2 variant was classified as likely benign. |
Gene |
RCV000606666 | SCV000714891 | benign | not specified | 2017-04-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000617986 | SCV000737979 | benign | Cardiovascular phenotype | 2017-04-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000776131 | SCV000911079 | benign | Cardiomyopathy | 2018-10-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000755675 | SCV001003479 | benign | Arrhythmogenic right ventricular dysplasia 10 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000755675 | SCV001284603 | likely benign | Arrhythmogenic right ventricular dysplasia 10 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV000776131 | SCV001334033 | benign | Cardiomyopathy | 2018-03-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000606666 | SCV001925083 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000171268 | SCV001928691 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000171268 | SCV001972067 | likely benign | not provided | no assertion criteria provided | clinical testing |